Tirzepatide’s links to changes in sleep apnea measures based on starting patient traits

Tirzepatide is associated with changes in apnea-hypopnea index (AHI), hypoxic burden, body weight, and blood pressure in patients with obstructive sleep apnea.

• Obstructive sleep apnea is linked to repetitive airway collapse during sleep.
• Excess body fat is a recognized risk factor for developing obstructive sleep apnea.
• The study aimed to evaluate how tirzepatide impacts various health measures in patients with obstructive sleep apnea.
• Patient characteristics such as age, sex, BMI, AHI, and neck circumference were considered in the assessment.

Simplified